Tokyo, Aug. 31 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059775) titled 'Research for novel markers reflecting pancreatic beta-cell disorders' on Aug. 31.
Study Type:
Observational
Primary Sponsor:
Institute - Kansai Electric Power Medical Research Institute
Condition:
Condition - Diabetes
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Identifying markers that more accurately reflect pancreatic b-cell disorders by using patients with type 1 diabetes as a stepping stone to a more predictable prognosis of b-cell function, which is a current challenge.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Mal...